MB49 In Vitro Thioredoxin Reductase Assay (Oxidative Stress)
CAT#: ITS-1022-YF3329
Target Cell Organism: Mouse
Target Cell Name: MB49
Assay Type: Oxidative Stress Assays
Assay Overview
This assay is to provide MB49-based In Vitro Thioredoxin Reductase Assay (Oxidative Stress) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
MB49
Target Cell Organism
Mouse
Target Cell Background
MB49 cells are derived from C57BL/Icrf-a' mouse bladder epithelial cells that were transformed by a single 24-hour treatment with the chemical carcinogen 7, 12-dimethylbenz[a]anthracene (DMBA) on the second day of a long term primary culture. Transformed cells transplanted into syngeneic mice were shown to generate carcinomas. While of male origin, karyotype analyses indicate the loss of the Y chromosome in 100% of the cells analyzed. This abnormality is a frequent early event in human bladder cancer.
Related Diseases
Bladder Cancer
Research Area
Oncology
Assay Name
In Vitro Thioredoxin Reductase Assay (Oxidative Stress)
Short Description
MB49-cell based In Vitro Thioredoxin Reductase Assay (Oxidative Stress)
Assay Description
Wide ranges of enzyme assays are also available to detect oxidative stress at the cellular level. Enzymes such as NO synthases and xanthine oxidase are known to generate ROS. Enzymes namely superoxide dismutase, catalase and thioredoxin reductase can prevent cells from oxidative damage. GST is another enzyme involved in oxidative stress that catalyzes the reduction of oxidized GSH to GSH.
Assay Type
Oxidative Stress Assays
Assay Type Details
Disturbance between the production of reactive oxygen species (ROS), free radicals and antioxidant mechanisms is defined as the oxidative stress, or more precisely, it is an imbalance between the oxidant and antioxidant state in cells. This imbalance can cause harmful effects to cells and biomolecules, which ultimately causes adverse effects in the whole organism. Oxidative imbalance can target important proteinsand lipids in cells, which can increase the risk of developing a cancer. On the other hand, increased ROS production in cancer cells by certain cancer drugs can also arrest cancer cell cycle and cause senescence and apoptosis through oxidative stress.